Evidence map›Paper›PMID 34815346›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Amyloid β 42 fibril structure based on small-angle scattering.

Veronica Lattanzi, Ingemar André, Urs Gasser, Marija Dubackic, Ulf Olsson, Sara Linse

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. The Importance of Being Imperfect: Structure and Function of Bacterial Amyloid.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Aducanumab binding to AβProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Aducanumab Binding to AβbioRxiv : the preprint server for biology · 2025
    Article
  7. Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  8. Article
  9. IntegratingJournal of the American Chemical Society · 2024
    Article
  10. The role of shear forces in primary and secondary nucleation of amyloid fibrils.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Structural characterization of E22G AβPhysical chemistry chemical physics : PCCP · 2024
    Article
  12. Article
  13. Article
  14. Self-replication of AProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Article
  17. The residual structure of acid-denatured βProtein science : a publication of the Protein Society · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Veronica LattanziBiochemistry and Structural Biology, Lund University, SE-22100 Lund, Sweden; veronica.lattanzi@biochemistry.lu.se.ORCID 0000-0001-7779-9680
Ingemar AndréBiochemistry and Structural Biology, Lund University, SE-22100 Lund, Sweden.
Urs GasserLaboratory for Neutron Scattering and Imaging, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland.ORCID 0000-0001-8137-1249
Marija DubackicBiochemistry and Structural Biology, Lund University, SE-22100 Lund, Sweden.ORCID 0000-0002-9037-828X
Ulf OlssonDivision of Physical Chemistry, Lund University, SE-22100 Lund, Sweden.
Sara LinseBiochemistry and Structural Biology, Lund University, SE-22100 Lund, Sweden.ORCID 0000-0001-9629-7109
Lund University · SEPaul Scherrer Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid fibrils are associated with a number of neurodegenerative diseases, including fibrils of amyloid β42 peptide (Aβ42) in Alzheimer's disease. These fibrils are a source of toxicity to neuronal cells through surface-catalyzed generation of toxic oligomers. Detailed knowledge of the fibril structure may thus facilitate therapeutic development. We use small-angle scattering to provide information on the fibril cross-section dimension and shape for Aβ42 fibrils prepared in aqueous phosphate buffer at pH = 7.4 and pH 8.0 under quiescent conditions at 37 °C from pure recombinant Aβ42 peptide. Fitting the data using a continuum model reveals an elliptical cross-section and a peptide mass-per-unit length compatible with two filaments of two monomers, four monomers per plane. To provide a more detailed atomistic model, the data were fitted using as a starting state a high-resolution structure of the two-monomer arrangement in filaments from solid-state NMR (Protein Data Bank ID 5kk3). First, a twofold symmetric model including residues 11 to 42 of two monomers in the filament was optimized in terms of twist angle and local packing using Rosetta. A two-filament model was then built and optimized through fitting to the scattering data allowing the two N-termini in each filament to take different conformations, with the same conformation in each of the two filaments. This provides an atomistic model of the fibril with twofold rotation symmetry around the fibril axis. Intriguingly, no polydispersity as regards the number of filaments was observed in our system over separate samples, suggesting that the two-filament arrangement represents a free energy minimum for the Aβ42 fibril.

Indexed as

Alzheimer DiseaseAmyloidAmyloid beta-PeptidesCatalysisCryoelectron MicroscopyDatabases, ProteinHumansHydrogen-Ion ConcentrationMagnetic Resonance SpectroscopyMicroscopy, Atomic ForceModels, MolecularMolecular ConformationNeurodegenerative DiseasesNeuronsPeptide FragmentsPeptidesAmyloidAmyloid beta-Peptidesamyloid beta-protein (1-42)Peptide FragmentsPeptidesamyloid-betaatomistic modelfibril structure in solutionnumber of filamentsSAXS/SANS

Identifiers

PMID34815346
PMCPMC8640717
OpenAlexW3216946234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.